Asymptomatic Carriage of SARS-CoV-2 in a University Population in Rosario, Argentina
Juan Pablo Scapini, María Victoria del Rosal, Juan Ignacio Isaac, Ayelen Rodriguez, Damian Ingaramo, Micaela Campora
Asian Journal of Research in Infectious Diseases · pp. 67–74 · Published 30 Oct 2023
10.9734/ajrid/2023/v14i3301Abstract
Aims: To study the rates of SARS-CoV-2 asymptomatic carriage in a young, healthy and full vaccinated population of students in the medical area. Contribute to the knowledge of the dynamics of the endemic and its control. Study Design: Cross-sectional descriptive study. Place and Duration of Study: Faculty of Medical Sciences, Instituto Universitario Italiano de Rosario, Argentina, between August and September 2022. Methodology: 300 students were recruited. An oropharyngeal sample was taken from all the participants who completed an online electronic survey. The sampling period corresponded to weeks of low viral circulation in the province. The presence of SARS-CoV-2 was investigated by real-time RT-PCR. Results: 72.7% of the participants reported a previous infection. All the participants received at least one dose of vaccine and 56.7% completed a 3-dose schedule. Two of the 300 samples were positive for SARS-CoV-2 RNA. One was classified as presymptomatic since the individual developed compatible symptoms three days after taking the sample. The other case was the only one classified as an asymptomatic carrier, resulting in a SARS-CoV-2 portability rate of 0.33%. Conclusion: The rate obtained for asymptomatic portability in our study was surprisingly low considering that these groups shared an average of 6 hours a day in closed environments. The risk of person to person spread in this population is extremely low and does not justify the use of masks or social distancing.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.